Sponsor pipeline

Energenesis Biomedical Co., Ltd. clinical trial pipeline

Get alerts when Energenesis Biomedical Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

First postedNew trial filingPhaseStatus
2026-10-05 NCT07858422 A Study to Evaluate ENERGI-F703EB Cream in Epidermolysis Bullosa Phase 2 Recruiting

Active trials by phase

Phase 2
2
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05930210 A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer Diabetic Foot Ulcer Recruiting 2025-10-02
Phase 2
NCT07858422 A Study to Evaluate ENERGI-F703EB Cream in Epidermolysis Bullosa Epidermolysis Bullosa (EB) Recruiting 2026-10-05
NCT07647614 A Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for Parkinson's Disease Parkinson's Disease (PD) Not Yet Recruiting 2026-07-02

Disease areas by active trials

Get alerts when Energenesis Biomedical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free